Wall Street Brief: A Fed hike, Orion180's below-range pricing, and a $7.7B broker take-private (2026)

Coverage window: September 11–18, 2026, through the Friday 18:00 publication cutoff in the channel's display timezone. One decision set the terms for everything else. On September 16 the Federal Open Market Committee raised the target range for the federal funds rate by a quarter point to 3.75%–4%, the first increase since 2023 and the first under Chair Kevin Warsh, on a 12–0 vote, saying the move would "support a timelier return" to the 2% goal. 1 The benchmark 10-year Treasury yield pushed past 5%, a level that market strategists had been tracking alongside crude near $100 a barrel as the point where equity buyers step back. 2

The repricing reached the primary market within about 36 hours. Orion180 Insurance Group sold its Nasdaq offering below the range it had filed a week earlier, and nuclear services company Holtec suspended its listing outright. 3 Two other central banks moved in the same direction inside the same window: the Bank of Japan raised its policy rate to 1.25% from 1% on September 18, a 31-year high, and the Bank of England held rates while stopping sales of government bonds from its balance sheet and forecasting UK inflation above 4% early next year. 4 5

Committed capital kept moving anyway, and mostly off the exchanges: a $7.7 billion take-private of an insurance broker, a $1.49 billion purchase of 60% of a Southeast Asian consumer lender, an agreed $2.9 billion buyout in Australia, and a $2.17 billion leveraged loan funding a specialty-pharmacy LBO. The week's two largest SEC actions pulled in opposite directions on investor access, with the agency proposing to stop overseeing shareholder proposals and separately opening tokenized stock trading to platforms that have never been registered exchanges.

At a glance

Area	Event	Stage and scale	Parties / advisers	Immediate read-through
IPO	Electra Therapeutics (ETRA)	Priced September 17; upsized to 23,333,334 shares at $15.00 for roughly $350 million gross; trading from September 18, closing September 21	Jefferies, TD Cowen, Evercore ISI and Cantor as joint book-running managers	The largest biotech pricing of the post-Labor Day window; price the registrational sHLH program against a 3,500,000-share option. 6
IPO	Orion180 Insurance Group (OIG)	Priced September 17 at $12.00, below the $15.00–$17.00 range filed September 9; 20 million shares for $240 million	RBC Capital Markets, UBS Investment Bank and Raymond James as lead book-running managers	A 20% cut below the bottom of the range is the clearest single read on how the rate week landed on primary-market demand. 3
IPO	Syngenta Group	Confidentially filed for a Hong Kong listing September 15; at least $5 billion, potentially $10 billion; launch targeted for late 2026 or early 2027	Sinochem (controlling shareholder); CEO Hengde Qin	At $10 billion it would be Hong Kong's largest listing since 2010, testing appetite for a group that Sinochem took private for $43 billion in 2017 and has never marked publicly. 7
M&A	The Baldwin Group (BWIN)	Definitive agreement September 14; $7.7 billion deal value; $32.50 a share in cash, about an 88% premium to the June 17 close	Sequence Holdings and DFO Management, Michael Dell's family office	A non-sponsor buyer paying an 88% premium resets the reference price for mid-market insurance distribution. 8
M&A	Grab / Atome Financial	Announced September 15; 60% for $1.49 billion, with the remaining 40% about two years after closing under a framework tied to Atome's EBITDA and revenue; values the target at $2 billion to $4.5 billion; completion expected by Q3 2027	Grab (GRAB); Atome Financial	Because the second tranche is performance-linked, most of the valuation risk sits past the first close. 9
M&A	Brookfield / Reliance Worldwide	Agreed September 16; almost $2.9 billion; $3.38 a share in cash, matching the earlier A$4.75 offer; shareholder vote required	Brookfield (BN.TO); AustralianSuper and Aware Super hold about 20.2% of Reliance	Two pension funds that rejected a Brookfield bid once before control the outcome. 10
Regulation	SEC shareholder-proposal and annual-report proposals	Proposed September 16; would end SEC review of shareholder proposals and drop the glossy annual-report requirement; comment period open	SEC Chair Paul S. Atkins	Removes the federal route for including or excluding a proposal and shifts the contest to state corporate law. 11
Regulation	SEC tokenized-securities exemption	Issued September 17; five-year exemption from exchange rules for platforms trading tokenized stocks, plus a dealer-registration carve-out for liquidity providers	SEC	Issuer notification and an issuer veto are conditions; synthetic tokens are excluded. 12
Regulation	CFTC v. Michael Frederick Staryk	Default judgment entered September 15 in the District of Connecticut; $547,616 restitution plus a $5,907,720 civil penalty, permanent trading and registration bans	CFTC; relief defendants Yvonne Stephanie Solerti-Coto and Global Financial Institution LLC ordered to disgorge $110,509.86	The penalty-to-restitution multiple of roughly 11x is the number to carry into retail solicitation risk assessments. 13
Firm guidance	Q3 fee outlook at the Barclays Global Financial Services Conference	September 14–16; industry investment-banking revenue reached $21.194 billion in Q3 through September 15, against $23.765 billion a year earlier	BofA (Brian Moynihan), JPMorgan (Doug Petno), Morgan Stanley (Daniel Simkowitz), Goldman Sachs (David Solomon)	Guidance spread from JPMorgan's mid-to-high-teens fee growth to BofA's decline of more than 10%, with Goldman flagging $500 million of extra non-compensation costs. 14 15
Personnel	State Street and Raymond James	State Street appointments effective September 14; Raymond James Bank Segment succession announced September 15, effective January 1, 2027	Mostapha Tahiri and Ann Fogarty (State Street); Steve Raney, Scott Curtis and Tarek Helal (Raymond James)	Both moves consolidate platform and banking oversight under executives who already ran adjacent businesses. 16 17
Financing	Goldman Sachs Alternatives private-equity close	Final close September 15; $11.7 billion raised across private-equity funds and related vehicles, led by $9.6 billion for West Street Capital Partners IX	Goldman Sachs Alternatives	A single sponsor raising $11.7 billion in one close is the clearest signal that LP commitments survived the July AI-trade unwind. 18 19
Financing	PANTHERx Rare LBO term loan	Launched September 18; $2.17 billion seven-year covenant-lite first-lien term loan, price talk S+300 area with an OID of 99.5; commitments due 5 p.m. ET on September 24	JPMorgan leads a 14-bank arranger group and is administrative agent; Warburg Pincus leads the buyer group	A roughly $7.5 billion LBO moving from private credit to the syndicated loan market is the week's clearest test of institutional demand at these yields. 20

Public capital

Electra Therapeutics prices an upsized $350 million Nasdaq offering

Electra Therapeutics priced 23,333,334 shares at $15.00 on September 17, raising about $350 million before underwriting discounts and offering expenses, and increased the deal from the size it had marketed. The company granted the underwriters 30 days to buy up to 3,500,000 additional shares at the public offering price, and all shares in the deal come from the company. Jefferies, TD Cowen, Evercore ISI and Cantor are joint book-running managers. The shares began trading on the Nasdaq Global Select Market on September 18 under ETRA, and the offering is expected to close September 21. 6

Proceeds fund ipsoprubart (ELA026), a pan-SIRP monoclonal antibody in a global registrational program for secondary hemophagocytic lymphohistiocytosis, a severe hyperinflammatory syndrome with no broadly approved therapy. Electra expects to complete enrollment in the second half of 2027, and a second candidate, ELA822, entered Phase 1 testing. 21

Electra is the 21st biotechnology company to price a US initial public offering in 2026 and the 11th to raise $300 million or more. The count of $300 million-plus biotech deals has already matched 2021's total for the year, and every company in that group had a drug in at least Phase 2 development. 21

Orion180 cuts its range and raises $240 million

Orion180 Insurance Group sold 20 million shares at $12.00 on September 17, raising $240 million and pricing below the $15.00–$17.00 range the company had set in its September 9 amended registration statement. RBC Capital Markets, UBS Investment Bank and Raymond James led the book. Orion180 writes excess-and-surplus homeowners insurance across 14 states, with Texas, California and Florida the largest markets. 3

The cut is the week's clearest evidence of what a rate shock does to a small-cap listing inside the pricing window. Holtec, a nuclear services company, suspended its planned offering during the same week and cited market conditions. 3 22 CVC-backed Bamboo Insurance launched its roadshow in the same window, seeking as much as $700 million at a $3.1 billion valuation, so the insurance pipeline stayed open even as individual deals were repriced. 23

Syngenta files for a Hong Kong listing of at least $5 billion

Syngenta Group confidentially filed for a Hong Kong initial public offering aiming to raise at least $5 billion, with the size potentially reaching $10 billion depending on market response, according to three people with direct knowledge of the filing. At $10 billion it would be Hong Kong's largest listing since 2010. The Basel-based seeds and agrichemicals group is controlled by Chinese state-owned Sinochem, which took it private for $43 billion in 2017 and has not since marked that investment to a public valuation. 7

Hong Kong's IPO market has raised $45.8 billion so far this year across new listings and secondary offerings, against $24 billion in the same period of 2025, according to LSEG data. Syngenta's filing revives an attempt that ended when it withdrew a planned Shanghai listing in 2024. 7

Elsewhere in listings, the National Stock Exchange of India's $2.3 billion offering was fully subscribed during the week, with the debut set for September 24. 24 May Mobility, an autonomous ride-hailing technology company, agreed to list on Nasdaq through a merger with blank-check firm ACP Holdings Acquisition in a deal valued at $1.4 billion that is expected to produce up to $337 million in gross proceeds, including a fully committed $120 million PIPE. 25

M&A

DFO Management and Sequence take Baldwin private for $7.7 billion

The Baldwin Group agreed on September 14 to be taken private by an entity formed by Sequence Holdings and DFO Management, Michael Dell's family office, in a transaction the companies valued at $7.7 billion. Baldwin shareholders receive $32.50 a share in cash, a premium of about 88% to the stock's June 17 close, the last price before reports of a possible deal. The shares rose 7.5% to $31.89 on the announcement. Baldwin's equity had been valued at about $4.14 billion. 8

Reuters reported the buyer rationale as flexibility to fund AI investments outside the quarterly reporting cycle. Diligence variables for the equity valuation include the split between the $7.7 billion headline figure and the roughly $4.14 billion equity value, the financing structure behind the cash consideration, and any remaining regulatory approvals. 8 26

Grab buys 60% of Atome Financial for $1.49 billion

Grab agreed on September 15 to acquire an initial 60% of Singapore-based Atome Financial for $1.49 billion, with a commitment to buy the remaining 40% about two years after closing under a framework tied to Atome's EBITDA and revenue. The structure values Atome somewhere between $2 billion and $4.5 billion and puts completion in the third quarter of 2027. 9

Atome brings buy-now-pay-later loans, consumer cash loans, BNPL cards and digital lending into Grab's financial services segment. Grab President and Chief Operating Officer Alex Hungate said the purchase allows the company to "leapfrog the timeline" for expansion into the Philippines, Indonesia and Thailand. Alongside the deal, Grab raised its 2028 targets to $1.7 billion of adjusted EBITDA and more than 30% compound annual revenue growth from 2025 to 2028; CFO Peter Oey said the financial services segment is expected to reach $500 million of adjusted EBITDA by 2028 on a combined gross loan portfolio above $6 billion. 9

Brookfield's $2.9 billion buyout of Reliance Worldwide goes to shareholders

Reliance Worldwide's board unanimously backed Brookfield's buyout of the Australian plumbing supplies company at almost $2.9 billion, the company said on September 16. Brookfield switched the currency of an August offer from Australian dollars to US dollars, bidding $3.38 a share in cash, equivalent to the earlier A$4.75 proposal. Shareholders can elect to be paid in either currency. 10

AustralianSuper and Aware Super own about 20.2% of Reliance between them, and AustralianSuper voted against Brookfield's $10.6 billion bid for Origin Energy in 2023, which investors ultimately rejected. Reliance's Americas sales fell 4% in its 2026 financial year and adjusted operating earnings fell more than 11%, with management attributing the decline to US tariffs, lower volumes and higher input costs. 10

Two large consumer deals enter UK merger review

Britain's Competition and Markets Authority opened an investigation on September 16 into the $65 billion combination of Unilever's foods business with US spice maker McCormick, announced in March, to assess the effect on UK competition. The transaction would leave Unilever and its shareholders with 65% of the fully diluted equity of the combined company, including a 9.9% stake held directly by Unilever. 27

The CMA also launched a probe on September 17 into AkzoNobel's $25 billion merger with coatings rival Axalta, and set November 11 as the deadline for its Phase 1 decision. 28

In a completed process, a consortium of FedEx, Advent International and other InPost investors secured 89.81% of the Polish parcel locker operator's shares, clearing the 80% minimum acceptance threshold on the €7.8 billion ($8.95 billion) all-cash offer at €15.60 a share. InPost has said the shares will be delisted from Euronext Amsterdam after closing. 29 Starbucks is exploring a sale of a majority stake in its Japan business, according to people familiar with the matter. 30

Regulation and market structure

The SEC proposes to stop overseeing shareholder proposals

The SEC on September 16 proposed ending its oversight of corporate shareholder votes on subjects such as climate and executive pay, and proposed dropping the rule that requires companies to produce a glossy annual report alongside Form 10-K. Chairman Paul S. Atkins said the agency lacks statutory authority to regulate shareholder proposals and that the area is better handled by states. The proposals now enter a public comment period. 11

New York State Comptroller Thomas DiNapoli, who oversees state retirement funds, described the shareholder proposal process as a cornerstone of US corporate governance for more than 80 years and said the proposal lets management shield itself from accountability. For asset managers with stewardship obligations, the practical effect is that company-specific exclusions and inclusions move from a federal review path to state corporate law and the courts. 11

A five-year exemption opens tokenized stock trading

The SEC issued an exemption on September 17 that allows platforms to offer trading in tokenized stocks and other securities without complying with many rules that apply to the Nasdaq, NYSE and other exchanges. The exemption runs five years and extends to liquidity providers in tokenized stocks, who are excused from dealer registration. Platforms must notify companies before listing a tokenized version of their stock and must withdraw the product if the issuer objects, and synthetic tokens that provide exposure through a derivative are excluded. 12

The SEC said the exemption was necessary because platforms offering tokenized stocks may struggle to comply with federal securities law without burdensome changes to their business models, and cited round-the-clock trading, instant settlement, self-custody and fractional ownership as potential benefits. Coinbase has said it plans to launch tokenized stocks in the US when rules allow; Robinhood and Kraken already offer them abroad. 12

Crypto market structure shifts from the Senate to the agencies

The Senate voted 49–50 on September 15 against advancing the Clarity Act, which would have established a regulatory framework for the cryptocurrency market, with four Republicans joining the opposition. The defeat came after the industry spent more than $300 million across the 2024 and 2026 election cycles, and analysts cited President Donald Trump's personal crypto dealings and lobbying by banks as factors that hardened opposition. 31

Two days later, on September 17, the CFTC sent its crypto market rulemaking to the White House Office of Information and Regulatory Affairs under RIN 3038-AF80, titled Regulation of Crypto Asset Transactions and Crypto Asset Markets. The filing sits at the pre-rule stage, with two comment periods and two OIRA reviews before a binding rule, and its contents remain confidential during review. 32

CFTC wins a $6.46 million options-fraud judgment

A default judgment entered in the US District Court for the District of Connecticut on September 15 ordered Michael Frederick Staryk, who did business as Magestic World Wide Finance, to pay $547,616 in restitution to defrauded clients and a $5,907,720 civil monetary penalty. The court permanently enjoined Staryk from violating the Commodity Exchange Act, imposed permanent trading and registration bans, and separately ordered relief defendants Yvonne Stephanie Solerti-Coto and Global Financial Institution LLC to disgorge $110,509.86 in client funds they had no legitimate claim to. 13

The CFTC's complaint alleged Staryk solicited at least 26 US retail clients for options trading on commodity futures contracts, never placed the trades, and misappropriated the funds. The judgment resolves a 2024 enforcement action. 13

The Fed's stress-test overhaul moves to a vote

Fed Vice Chair for Supervision Michelle Bowman said on September 18 that the central bank will vote on a final version of its revised stress test in the coming weeks. The new process will disclose the models, equations and variables the Fed uses, publish more detail on the annual hypothetical economic scenarios, and average the results of a bank's two most recent tests when assigning the stress capital buffer. 33

Banks sued the Fed in 2024 over the exams, which set additional capital requirements for the largest lenders. Any change to how the buffer is calculated feeds directly into capital planning and buyback capacity for the firms in this brief. 33

Firm earnings and guidance

No Q3 results yet, and the guidance gap between peers widened

No bulge-bracket firm reported quarterly results in this window; third-quarter earnings season opens in mid-October. What the window did produce was forward guidance from the Barclays Global Financial Services Conference, and the range was unusually wide. 14

Bank of America CEO Brian Moynihan said on September 14 that he expects the bank's investment-banking fees to fall by at least 10% in the third quarter, with revenue of $1.6 billion to $1.8 billion against $2 billion a year earlier, and sales and trading revenue roughly flat against $5.4 billion. He described the industry's investment-banking market as down about 10% and said BofA would decline a bit more. The shares fell more than 5%. 14

JPMorgan co-president Doug Petno, who runs the commercial and investment bank, said on September 15 that he expects third-quarter investment banking and trading fees to be up in the mid to high teens from a year earlier, with clients "seeing through the market volatility and the fog of uncertainty." The shares finished more than 1% higher. At the same conference, Morgan Stanley co-president Daniel Simkowitz said third-quarter activity does not compare with the second. 34

Goldman Sachs CEO David Solomon told the conference on September 16 that fixed income, currencies and commodities would be "a little bit softer on a relative basis" in the third quarter while equities remain very strong, and that transaction expenses are running higher with some technology spending pulled forward, lifting non-compensation expenses by $500 million. Goldman shares fell almost 4% in a session when bank stocks were weaker across the board after the Fed's decision. 15

The aggregate backs BofA's read more than JPMorgan's. Global investment-banking revenue reached $21.194 billion in the third quarter through September 15, against $23.765 billion a year earlier, according to Dealogic, with M&A and debt raising both slower. 15 For compliance and relationship teams, the split matters more than the average: the same quarter is a record for one firm's equities desk and a shortfall for another's advisory pipeline.

Personnel

State Street reallocates platform and operations leadership

State Street announced appointments effective September 14. Mostapha Tahiri, previously enterprise chief operating officer, becomes president of State Street Alpha, responsible for the Alpha platform, Charles River Development and related platform solutions, reporting to Chairman and CEO Ron O'Hanley, and also becomes chairman of Asia Pacific. Ann Fogarty, previously Investment Services chief operating officer, succeeds Tahiri as enterprise COO and will lead enterprise technology and operations, continuing to co-lead the firm's transformation program with CFO John Woods. 16

Raymond James sets out Bank Segment succession

Raymond James Financial said on September 15 that Bank Segment President Steve Raney will move into an executive consulting role on January 1, 2027, after 21 years leading the firm's banking business. Chief Operating Officer Scott Curtis will lead the Bank Segment while keeping oversight of Raymond James Investment Management, marketing, corporate real estate and procurement. Chief Strategy Officer Tarek Helal will additionally oversee Asset Management Services from the same date. CEO Paul Shoukry noted that the segment grew from about $41 million in annual net revenues in fiscal 2006 to nearly $1.8 billion in fiscal 2025. Raney will remain chair of the Raymond James Bank board and a member of the TriState Capital Bank and trust company boards. 17

Also this week, Michael Burry joined Minerva Investment Management as a senior adviser for a new short-focused fund. 35

Financing and capital markets

Goldman Sachs Alternatives closes $11.7 billion of private equity

Goldman Sachs Alternatives completed fundraising for its latest private-equity funds and related vehicles at $11.7 billion, the firm said on September 15, led by a $9.6 billion final close for flagship buyout fund West Street Capital Partners IX. The total includes an Asia-Pacific fund and co-investment vehicles. 18 19

The close is the largest single-sponsor private-equity raise reported in this window, and it lands in the same week that two sponsors committed to large take-privates. For limited partners evaluating re-ups, the relevant figure is the $9.6 billion flagship close rather than the $11.7 billion headline across vehicles.

PANTHERx Rare takes a $7.5 billion LBO to the syndicated loan market

PANTHERx Rare launched a $2.17 billion first-lien term loan on September 18 to part-finance a buyout by a Warburg Pincus-led investor group. Commitments are due 5 p.m. ET on September 24. Price talk on the seven-year covenant-lite loan is S+300 area with a 0% floor and an original issue discount of 99.5, implying a yield to maturity of about 7.14%, with two leverage-based margin step-downs of 25 basis points at 4.5x and 4x first-lien net leverage and a further 25 basis points on an IPO. Lenders get six months of 101 soft call protection. 20

JPMorgan leads an arranger group that also includes Goldman Sachs, Citi, Jefferies, Morgan Stanley, Wells Fargo, UBS, Santander, Truist Securities, Fifth Third, SMBC, Citizens and Natixis, and is administrative agent. The borrower is Puma Buyer LLC. S&P Global Ratings assigned the loan B+ with a stable outlook and a 3 recovery rating on September 14; Moody's assigned a B2 corporate rating and B1 first-lien facility rating. The roughly $7.5 billion LBO also carries a privately placed $470 million second-lien term loan due 2034 and a $300 million revolver due 2031. Existing PANTHERx debt sits with private credit lenders, including a first-lien term loan due March 2032 priced at S+425 as of June 30, so the new package refinances that exposure into the broadly syndicated market. 20

What to carry into next week

PANTHERx Rare term loan (September 24): Commitments close at 5 p.m. ET. Pricing at or inside S+300 area against the S+425 the existing private credit facility carried sets the tone for other sponsor borrowers refinancing into the syndicated market.
Electra Therapeutics (ETRA): The offering is scheduled to close September 21. Track settlement, and whether the 3,500,000-share option is exercised, since final proceeds move with it.
National Stock Exchange of India: Subscription closes September 21 and the debut is set for September 24. The listing outcome is the largest single test of the Asian primary market this month.
Q3 earnings season: Bank results begin in mid-October. Compare reported investment-banking and trading revenue against BofA's "down more than 10%" guidance and JPMorgan's "mid to high teens" growth, and check whether Goldman's $500 million non-compensation cost increase holds.
SEC comment period: The shareholder-proposal and annual-report proposals are open for comment, and the tokenized-securities exemption carries its own conditions on issuer notification and veto. Both are worth routing to legal and to stewardship teams this week rather than at implementation.
CFTC crypto rulemaking: RIN 3038-AF80 is at the pre-rule stage with two comment periods and two OIRA reviews ahead. Treat it as a multi-quarter process.
AkzoNobel / Axalta (November 11): The CMA's Phase 1 decision deadline is the next hard date in that deal; the McCormick / Unilever investigation is running on its own timetable.
Rate path: The next FOMC meeting is scheduled for October 27–28. With the 10-year yield above 5% and oil near $100, watch whether further tightening slows the financing demand that currently keeps the deal pipeline full.